Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study

被引：0

作者：

Rieke Alten

Xavier Mariette

René-Marc Flipo

Roberto Caporali

Maya H. Buch

Yusuf Patel

Sara Marsal

Raimon Sanmartí

Michael T. Nurmohamed

Hedley Griffiths

Peter Peichl

Bettina Bannert

Melanie Chartier

Sean E. Connolly

Karissa Lozenski

Christiane Rauch

机构：

[1] University Medicine Berlin,Schlosspark

[2] Université Paris-Saclay,Klinik

[3] AP-HP,undefined

[4] Hospital Bicêtre,undefined

[5] INSERM UMR1184,undefined

[6] Centre Hospitalier Universitaire de Lille,undefined

[7] University of Milan,undefined

[8] G. Pini Hospital,undefined

[9] University of Leeds,undefined

[10] University of Manchester and NIHR Manchester Biomedical Research Centre,undefined

[11] Hull University Teaching Hospitals NHS Trust,undefined

[12] Hospital Universitari Vall d’Hebron,undefined

[13] Hospital Clínic de Barcelona,undefined

[14] ARC Amsterdam University Hospitals – VU University Medical & Reade,undefined

[15] University Hospital Geelong,undefined

[16] Evangelical Hospital,undefined

[17] Universitätsspital Basel,undefined

[18] Bristol Myers Squibb,undefined

[19] Bristol Myers Squibb,undefined

[20] Bristol Myers Squibb,undefined

来源：

Clinical Rheumatology | 2022年 / 41卷

关键词：

Abatacept; Biological therapy; Retention; Rheumatoid arthritis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2361 / 2373

页数：12

共 50 条

[1] Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
Alten, Rieke
Mariette, Xavier
Flipo, Rene-Marc
Caporali, Roberto
Buch, Maya H.
Patel, Yusuf
Marsal, Sara
Sanmarti, Raimon
Nurmohamed, Michael T.
Griffiths, Hedley
Peichl, Peter
Bannert, Bettina
Chartier, Melanie
Connolly, Sean E.
Lozenski, Karissa
Rauch, Christiane
[J]. CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2361 - 2373
[2] ABATACEPT RETENTION RATES AND PROGNOSTIC FACTORS OF RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: 2-YEAR RESULTS FROM THE REAL-WORLD ACTION STUDY
Alten, R.
Lorenz, H-M.
Mariette, X.
Nuesslein, H.
Galeazzi, M.
Navarro, F.
Chartier, M.
Elbez, Y.
Rauch, C.
Le Bars, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 577 - 578
[3] Abatacept Retention Rates and Prognostic Factors of Retention in Patients with Rheumatoid Arthritis (RA) Treated in Canada: 2-Year Results from a Real-World Observational Study
Haraoui, Boulos
Choquette, Denis
Bessette, Louis
Khraishi, Majed
Maoui, Meryem
Heitzmann, Julia
Connolly, Sean
Alten, Rieke
[J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 980 - 980
[4] ASCORE, A 2-YEAR, OBSERVATIONAL, PROSPECTIVE MULTICENTRE STUDY OF SUBCUTANEOUS ABATACEPT FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN ROUTINE CLINICAL PRACTICE: 1-YEAR INTERIM ANALYSIS
Alten, Rieke
Mariette, Xavier
Buch, Maya
Caporali, Roberto
Flipo, Rene-Marc
Forster, Adrian
Nurmohamed, Michael
Patel, Yusuf
Peichl, Peter
Sanmarti, Raimon
Chartier, Melanie
Heitzmann, Julia
Rauch, Christiane
Connolly, Sean
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1639 - 1639
[5] Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study
Peichl, Peter
Alten, Rieke
Galeazzi, Mauro
Lorenz, Hanns-Martin
Nuesslein, Hubert
Navarro, Federico
Elbez, Yedid
Chartier, Melanie
Hackl, Roland
Rauch, Christiane
Connolly, Sean E.
[J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2020, 170 (5-6) : 132 - 140
[6] Abatacept Retention Rates, Overall and By Participating Country, and Prognostic Factors of Retention in Patients with RA: 2-Year Results from a Real-World Observational Study
Alten, Rieke
Lorenz, H. M.
Mariette, X.
Nuesslein, H. G.
Galeazzi, M.
Navarro, F.
Chartier, M.
Elbez, Y.
Rauch, C.
Le Bars, M.
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[7] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
Alten, Rieke
Mariette, Xavier
Lorenz, Hanns-Martin
Nuesslein, Hubert
Galeazzi, Mauro
Navarro, Federico
Chartier, Melanie
Heitzmann, Julia
Poncet, Coralie
Rauch, Christiane
Le Bars, Manuela
[J]. CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1413 - 1424
[8] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
Rieke Alten
Xavier Mariette
Hanns-Martin Lorenz
Hubert Nüßlein
Mauro Galeazzi
Federico Navarro
Melanie Chartier
Julia Heitzmann
Coralie Poncet
Christiane Rauch
Manuela Le Bars
[J]. Clinical Rheumatology, 2019, 38 : 1413 - 1424
[9] Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study
Nuesslein, H. G.
Alten, R.
Galeazzi, M.
Lorenz, H. -M.
Nurmohamed, M. T.
Bensen, W. G.
Burmester, G. R.
Peter, H. -H.
Peichl, P.
Pavelka, K.
Chartier, M.
Poncet, C.
Rauch, C.
Le Bars, M.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : 489 - 499
[10] Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
Rieke Alten
Xavier Mariette
Hanns-Martin Lorenz
Hubert Nüßlein
Mauro Galeazzi
Federico Navarro
Melanie Chartier
Julia Heitzmann
Coralie Poncet
Christiane Rauch
Manuela Le Bars
[J]. Clinical Rheumatology, 2019, 38 : 1535 - 1535

← 1 2 3 4 5 →